Tumor Tip of the Week-04-12-2024 LAMN Histology and Behavior - Omega Healthcare

Tumor Tip of the Week-04-12-2024 LAMN Histology and Behavior

Tumor Tip header image

04-12-2024 LAMN Histology and Behavior

Match the Scenario with the correct Answer:

Answer: Histology/Behavior Code: 8480/3

  1. 2021 Appendectomy: LAMN diffusely involving the appendix and perforating the visceral peritoneum, as extensive intraperitoneal mets.   2023 Lung wedge resection: metastatic mucinous neoplasm involving lung parenchyma and pleura, consistent with metastasis of the known appendiceal primary
  2. 2023 Patient who presented with right lower quadrant pain and a CT scan confirming appendicitis, no lymph node or metastatic disease seen. Laparoscopic appendectomy: 2cm Low-grade appendiceal mucinous neoplasm. Tumor invades through muscularis propria into subserosa or mesoappendix but does not extend to serosal surface. No Regional lymph nodes removed. pT3
  3. 2023 Patient who presented with right lower quadrant pain and a CT scan confirming appendicitis, no lymph node or metastatic disease seen. Laparoscopic appendectomy: 2cm Low-grade appendiceal mucinous neoplasm confined to the muscularis propria. No Regional lymph nodes removed. pTis(LAMN)

Scenario B matches the Answer 8480/3 See discussion below:

  1. This case would not be reportable. LAMN is reportable starting with cases diagnosed in 2022. Pre-2022 LAMN is not reportable even when treated with surgery and chemotherapy. [SEER Sinq 20230007]
  2. This case is reportable. Histology would be 8480/3 per Colon Solid Tumor Rules/AJCC v9 pT3 pNx cM0 Stage 99
  • Rule H6 Code invasive mucinous adenocarcinoma 8480 when the diagnosis is any of the following:
    • The pathologist has staged the LAMN as T3 or T4
  1. This case is reportable. Histology would be 8480/2 per Colon Solid Tumor Rules / AJCC v9 pTis (LAMN) cN0 cM0 Stage 0
  • STR Rule H5 Code low grade appendiceal mucinous neoplasm (LAMN) and high grade appendiceal mucinous neoplasm (HAMN) 8480/2 when:
  • Diagnosis date is 1/1/2022 forward AND
    • Behavior is stated to be in situ/non-invasive OR
    • Behavior is not indicated

Tip:

Watch the NAACCR Webinars Lower GI Part 1 & 2 presented 06-2023.

*Omega Staff this is available on the Cancer Registry Education SharePoint site

*If not on Omega staff, please check with your State Registry to see if these Webinars might be available for viewing

Comments are closed.